Structure-activity relationships of SPARSOMYCIN (cas 1404-64-4): modification at the hydroxyl groupRelations structure-activité de la SPARSOMYCIN (cas 1404-64-4)e: modification du groupement hydroxyle
-
Add time:09/06/2019 Source:sciencedirect.com
Ten analogues of the antibiotic sparsomycin were prepared and evaluated in several in vitro tests. Nine of them carry a modification at the hydroxymethylene group of the molecules, two have a disulfide bond instead of the S(O)-CH2-S moiety at the sulfur-containing side chain of the molecules. While the presence of the S-S group decreases the activity of the analogues in all the tests performed, the modification at the OH group has no deleterious effects on the activity when a polyphenylalanine synthesis assay is used in an Escherichia coli extract. The same modifications, however, diminish drastically the activity of the analogues when tested in a similar Saccharomyces cerevisiae extract. A polymerization system in the archaebacterium Halobacterium halobium extract behaves like the eukaryotic preparations. A discrepancy is also found between the results of the polymerization tests and those of the ‘puromycin reaction’ which is also less sensitive to the modified sparsomycin analogues.The results of cell growth inhibition tests in bacteria as well as in eukaryotic organisms agree only partially with the in vitro data.
We also recommend Trading Suppliers and Manufacturers of SPARSOMYCIN (cas 1404-64-4). Pls Click Website Link as below: cas 1404-64-4 suppliers
Prev:Potentiation of cisplatin antitumor activity on L1210 leukemia s.c. by SPARSOMYCIN (cas 1404-64-4) and three of its analogues
Next:The biosynthesis of SPARSOMYCIN (cas 1404-64-4). Further investigations of the biosynthesis of the uracil acrylic acid moiety) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticleSynthesis of SPARSOMYCIN (cas 1404-64-4) Analogs as Potential Antitumor Agents09/09/2019
- Synthesis and morphological reversion activity on srctsNRK cells of pyrimidinylpropanamide antibiotics, SPARSOMYCIN (cas 1404-64-4), sparoxomycin A1, A2, and their analogues09/08/2019
- The biosynthesis of SPARSOMYCIN (cas 1404-64-4). Further investigations of the biosynthesis of the uracil acrylic acid moiety09/07/2019
- Potentiation of cisplatin antitumor activity on L1210 leukemia s.c. by SPARSOMYCIN (cas 1404-64-4) and three of its analogues09/05/2019
- Original paperAntitumour activity and retinotoxicity of ethyldeshydroxy-SPARSOMYCIN (cas 1404-64-4) in mice09/04/2019
- ORGINAL ARTICLEBiochemical studies on the production of SPARSOMYCIN (cas 1404-64-4) antibiotic by Pseudomonas aeurginosa, AZ-SH-B8 using plastic wastes as fermented substrate09/03/2019
- DispatchRibosomal translocation: SPARSOMYCIN (cas 1404-64-4) pushes the button09/02/2019
- Genome NoteDraft genome sequence of broad-spectrum antibiotic SPARSOMYCIN (cas 1404-64-4)-producing Streptomyces sparsogenes ATCC 25498 from the American Type Culture Collection09/01/2019


